Back in 2015, the researchers at Mount Sinai identified harmine, a drug belonging to DYRK1A inhibitors, the compound capable of activating insulin-producing human beta cell regeneration.

Now, a recent study in Cell Metabolism describes the application of a novel phenotypic screening approach that identified the small molecule harmine, which exhibits beneficial effects similar to ...

R esearchers assessed whether combining psychedelics, namely DMT and harmine as two active ingredients in ayahuasca, with meditation increases mindfulness, compassion, insight, and mystical-type ...